India Generics Market Summary, Competitive Analysis and Forecast, 2017-2026
![](/report_cover/4228/india-generics-market-summary-competitive-analysis-n-forecast-2017-2026_en.gif)
India Generics Market @Summary, Competitive Analysis and Forecast, 2017-2026
SUMMARY
Generics in India industry profile provides top-line qualitative and quantitative summary information including: market share, market size (value and volume 2017-21, and forecast to 2026). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market.
KEY HIGHLIGHTS
SUMMARY
Generics in India industry profile provides top-line qualitative and quantitative summary information including: market share, market size (value and volume 2017-21, and forecast to 2026). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market.
KEY HIGHLIGHTS
- For the purposes of this profile, a generic drug is defined as a copy of an ethical (prescription) drug formerly protected by patents that have now expired. Both unbranded generics and all branded generics are included. However, off-patent drugs that continue to be offered by the original manufacturer under the original name, and which form part of the 'generic-eligible' market, are not included.
- The Indian generics market had total revenues of $17.3 billion in 2021, representing a compound annual growth rate (CAGR) of 8.1% between 2016 and 2021.
- Market consumption volume increased with a CAGR of 0.5% between 2016 and 2021, to reach a total of 97.5 % in 2021.
- Over the past five years, the Indian market recorded growth of 8.5%. Growth in the market has been driven by demographic trends and increased awareness.
- Save time carrying out entry-level research by identifying the size, growth, major segments, and leading players in the generics market in India
- Use the Five Forces analysis to determine the competitive intensity and therefore attractiveness of the generics market in India
- Leading company profiles reveal details of key generics market players’ global operations and financial performance
- Add weight to presentations and pitches by understanding the future growth prospects of the India generics market with five year forecasts by both value and volume
- What was the size of the India generics market by value in 2021?
- What will be the size of the India generics market in 2026?
- What factors are affecting the strength of competition in the India generics market?
- How has the market performed over the last five years?
- Who are the top competitors in India's generics market?
1 EXECUTIVE SUMMARY
1.1. Market value
1.2. Market value forecast
1.3. Market volume
1.4. Market volume forecast
1.5. Geography segmentation
1.6. Market rivalry
1.7. Competitive Landscape
2 MARKET OVERVIEW
2.1. Market definition
2.2. Market analysis
3 MARKET DATA
3.1. Market value
3.2. Market volume
4 MARKET SEGMENTATION
4.1. Geography segmentation
5 MARKET OUTLOOK
5.1. Market value forecast
5.2. Market volume forecast
6 FIVE FORCES ANALYSIS
6.1. Summary
6.2. Buyer power
6.3. Supplier power
6.4. New entrants
6.5. Threat of substitutes
6.6. Degree of rivalry
7 COMPETITIVE LANDSCAPE
7.1. Who are the leading players?
7.2. What are the strengths/weaknesses of the leading players?
7.3. Has there been any significant recent M&A activity?
7.4. How did the COVID-19 pandemic impact leading players?
8 COMPANY PROFILES
8.1. Sun Pharmaceutical Industries Ltd
8.2. Lupin Ltd
8.3. Aurobindo Pharma Ltd
8.4. Cipla Limited
9 MACROECONOMIC INDICATORS
9.1. Country data
10 APPENDIX
10.1. Methodology
10.2. Industry associations
10.3. Related MarketLine research
10.4. About MarketLine
1.1. Market value
1.2. Market value forecast
1.3. Market volume
1.4. Market volume forecast
1.5. Geography segmentation
1.6. Market rivalry
1.7. Competitive Landscape
2 MARKET OVERVIEW
2.1. Market definition
2.2. Market analysis
3 MARKET DATA
3.1. Market value
3.2. Market volume
4 MARKET SEGMENTATION
4.1. Geography segmentation
5 MARKET OUTLOOK
5.1. Market value forecast
5.2. Market volume forecast
6 FIVE FORCES ANALYSIS
6.1. Summary
6.2. Buyer power
6.3. Supplier power
6.4. New entrants
6.5. Threat of substitutes
6.6. Degree of rivalry
7 COMPETITIVE LANDSCAPE
7.1. Who are the leading players?
7.2. What are the strengths/weaknesses of the leading players?
7.3. Has there been any significant recent M&A activity?
7.4. How did the COVID-19 pandemic impact leading players?
8 COMPANY PROFILES
8.1. Sun Pharmaceutical Industries Ltd
8.2. Lupin Ltd
8.3. Aurobindo Pharma Ltd
8.4. Cipla Limited
9 MACROECONOMIC INDICATORS
9.1. Country data
10 APPENDIX
10.1. Methodology
10.2. Industry associations
10.3. Related MarketLine research
10.4. About MarketLine
LIST OF TABLES
Table 1: India generics market value: $ billion, 2016-21
Table 2: India generics market volume: %, 2016-21
Table 3: India generics market geography segmentation: $ billion, 2021
Table 4: India generics market value forecast: $ billion, 2021-26
Table 5: India generics market volume forecast: %, 2021-26
Table 6: Sun Pharmaceutical Industries Ltd: key facts
Table 7: Sun Pharmaceutical Industries Ltd: Annual Financial Ratios
Table 8: Sun Pharmaceutical Industries Ltd: Key Employees
Table 9: Sun Pharmaceutical Industries Ltd: Key Employees Continued
Table 10: Lupin Ltd: key facts
Table 11: Lupin Ltd: Annual Financial Ratios
Table 12: Lupin Ltd: Key Employees
Table 13: Lupin Ltd: Key Employees Continued
Table 14: Aurobindo Pharma Ltd: key facts
Table 15: Aurobindo Pharma Ltd: Annual Financial Ratios
Table 16: Aurobindo Pharma Ltd: Key Employees
Table 17: Cipla Limited: key facts
Table 18: Cipla Limited: Annual Financial Ratios
Table 19: Cipla Limited: Key Employees
Table 20: India size of population (million), 2017-21
Table 21: India gdp (constant 2005 prices, $ billion), 2017-21
Table 22: India gdp (current prices, $ billion), 2017-21
Table 23: India inflation, 2017-21
Table 24: India consumer price index (absolute), 2017-21
Table 25: India exchange rate, 2017-21
Table 1: India generics market value: $ billion, 2016-21
Table 2: India generics market volume: %, 2016-21
Table 3: India generics market geography segmentation: $ billion, 2021
Table 4: India generics market value forecast: $ billion, 2021-26
Table 5: India generics market volume forecast: %, 2021-26
Table 6: Sun Pharmaceutical Industries Ltd: key facts
Table 7: Sun Pharmaceutical Industries Ltd: Annual Financial Ratios
Table 8: Sun Pharmaceutical Industries Ltd: Key Employees
Table 9: Sun Pharmaceutical Industries Ltd: Key Employees Continued
Table 10: Lupin Ltd: key facts
Table 11: Lupin Ltd: Annual Financial Ratios
Table 12: Lupin Ltd: Key Employees
Table 13: Lupin Ltd: Key Employees Continued
Table 14: Aurobindo Pharma Ltd: key facts
Table 15: Aurobindo Pharma Ltd: Annual Financial Ratios
Table 16: Aurobindo Pharma Ltd: Key Employees
Table 17: Cipla Limited: key facts
Table 18: Cipla Limited: Annual Financial Ratios
Table 19: Cipla Limited: Key Employees
Table 20: India size of population (million), 2017-21
Table 21: India gdp (constant 2005 prices, $ billion), 2017-21
Table 22: India gdp (current prices, $ billion), 2017-21
Table 23: India inflation, 2017-21
Table 24: India consumer price index (absolute), 2017-21
Table 25: India exchange rate, 2017-21
LIST OF FIGURES
Figure 1: India generics market value: $ billion, 2016-21
Figure 2: India generics market volume: %, 2016-21
Figure 3: India generics market geography segmentation: % share, by value, 2021
Figure 4: India generics market value forecast: $ billion, 2021-26
Figure 5: India generics market volume forecast: %, 2021-26
Figure 6: Forces driving competition in the generics market in India, 2021
Figure 7: Drivers of buyer power in the generics market in India, 2021
Figure 8: Drivers of supplier power in the generics market in India, 2021
Figure 9: Factors influencing the likelihood of new entrants in the generics market in India, 2021
Figure 10: Factors influencing the threat of substitutes in the generics market in India, 2021
Figure 11: Drivers of degree of rivalry in the generics market in India, 2021
Figure 1: India generics market value: $ billion, 2016-21
Figure 2: India generics market volume: %, 2016-21
Figure 3: India generics market geography segmentation: % share, by value, 2021
Figure 4: India generics market value forecast: $ billion, 2021-26
Figure 5: India generics market volume forecast: %, 2021-26
Figure 6: Forces driving competition in the generics market in India, 2021
Figure 7: Drivers of buyer power in the generics market in India, 2021
Figure 8: Drivers of supplier power in the generics market in India, 2021
Figure 9: Factors influencing the likelihood of new entrants in the generics market in India, 2021
Figure 10: Factors influencing the threat of substitutes in the generics market in India, 2021
Figure 11: Drivers of degree of rivalry in the generics market in India, 2021